Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 trial update of tirzepatide (LY3298176) in Japanese participants with type 2 diabetes completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2023-03-23